Adaptive design of clinical trials : understanding the barriers to adoption

Thesis: M.B.A., Massachusetts Institute of Technology, Sloan School of Management, 2014.

Bibliographic Details
Main Author: Khalid, Ayesha N. (Ayesha Naz)
Other Authors: Andrew Lo.
Format: Thesis
Language:eng
Published: Massachusetts Institute of Technology 2014
Subjects:
Online Access:http://hdl.handle.net/1721.1/90220
_version_ 1811097438359912448
author Khalid, Ayesha N. (Ayesha Naz)
author2 Andrew Lo.
author_facet Andrew Lo.
Khalid, Ayesha N. (Ayesha Naz)
author_sort Khalid, Ayesha N. (Ayesha Naz)
collection MIT
description Thesis: M.B.A., Massachusetts Institute of Technology, Sloan School of Management, 2014.
first_indexed 2024-09-23T16:59:32Z
format Thesis
id mit-1721.1/90220
institution Massachusetts Institute of Technology
language eng
last_indexed 2024-09-23T16:59:32Z
publishDate 2014
publisher Massachusetts Institute of Technology
record_format dspace
spelling mit-1721.1/902202019-04-11T06:11:30Z Adaptive design of clinical trials : understanding the barriers to adoption Khalid, Ayesha N. (Ayesha Naz) Andrew Lo. Sloan School of Management. Sloan School of Management. Sloan School of Management. Thesis: M.B.A., Massachusetts Institute of Technology, Sloan School of Management, 2014. Cataloged from PDF version of thesis. Includes bibliographical references (pages 69-72). There is great competition for clinical research funding. This is in part due to the National Institute of Health's reduced budget to support such initiatives. It has resulted in a growing trend for clinical research to use adaptive design models to accelerate clinical trials and at the same time reduce overall cost. Although such models have existed for several years, the pace of adoption remains slow, especially for early-stage clinical research. Through a review of relevant literature and interviews with industry experts, this thesis explores the barriers that inhibit the adoption of adaptive design of clinical trials. Reasons uncovered include: a lack of novel funding mechanisms, regulatory uncertainty, logistical difficulties, overly technical communications, a lack of collaboration among stakeholders, and an inability to recruit and retain patients. Then follows a series of possible solutions - some already functioning, others possible - for each of the barriers. This research found that unless efforts are devoted to addressing these underlying barriers, the widespread adoption of adaptive designs for clinical trials will not occur. The thesis concludes with recommendations and suggestions for future research. by Ayesha N. Khalid. M.B.A. 2014-09-19T21:46:52Z 2014-09-19T21:46:52Z 2014 2014 Thesis http://hdl.handle.net/1721.1/90220 890374351 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 72 pages application/pdf Massachusetts Institute of Technology
spellingShingle Sloan School of Management.
Khalid, Ayesha N. (Ayesha Naz)
Adaptive design of clinical trials : understanding the barriers to adoption
title Adaptive design of clinical trials : understanding the barriers to adoption
title_full Adaptive design of clinical trials : understanding the barriers to adoption
title_fullStr Adaptive design of clinical trials : understanding the barriers to adoption
title_full_unstemmed Adaptive design of clinical trials : understanding the barriers to adoption
title_short Adaptive design of clinical trials : understanding the barriers to adoption
title_sort adaptive design of clinical trials understanding the barriers to adoption
topic Sloan School of Management.
url http://hdl.handle.net/1721.1/90220
work_keys_str_mv AT khalidayeshanayeshanaz adaptivedesignofclinicaltrialsunderstandingthebarrierstoadoption